drugset / Trial / NCT05896137
CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis)
RandomizedParallel-groupDouble-blindTreatment
Summary
A phase II Study of CS0159 in Chinese patients with PSC(Primary Sclerosing Cholangitis)
Timeline
- Start
- 2023-08-07
- Primary completion
- 2025-11-14
- Completion
- 2026-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CS0159 | Unknown | 2 mg | Oral |
| Subject | CS0159 | Unknown | 4 mg | Oral |